KINESIOTAPING IN DISCOPATHIES AND DEGENERATIVE SPINAL DISEASES: SYSTEMATIC REVIEW
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接:
https://figshare.com/articles/dataset/KINESIOTAPING_IN_DISCOPATHIES_AND_DEGENERATIVE_SPINAL_DISEASES_SYSTEMATIC_REVIEW/23573992
下载链接
链接失效反馈官方服务:
资源简介:
ABSTRACT Neuromuscular taping or kinesiotaping is a technique widely used in spinal disorders. However, the scientific evidence of its use in discopathies and degenerative spine pathology is unknown. This study aimed to analyze the published clinical trials on neuromuscular taping in subjects with discopathies and degenerative spinal injuries. For this purpose, a literature search was performed following PRISMA guidelines in the following databases: PubMed, Web of Science (WOS), Scopus, Medline, and Cinahl. In analyzing bias and methodological quality, we used: the PEDro scale, Van Tulder criteria, and risk of bias analysis of the Cochrane Collaboration. A total of 5 articles were included that obtained a mean score of 6.2 on the PEDro scale. There is moderate evidence that, in the short term, neuromuscular taping reduces analgesic consumption and improves the range of motion and muscle strength in the posterior musculature. In addition, there is limited evidence that it can improve quality, while the scientific evidence on the effect of neuromuscular taping on pain is contradictory. The application of neuromuscular taping on discopathies and degenerative processes of the spine should be cautiously undertaken until more conclusive results are obtained, and the long-term effects are assessed. Level of evidence I; Systematic review.
【摘要】肌内效贴(neuromuscular taping)是一种广泛应用于脊柱疾病的治疗技术。然而,其在椎间盘病变与退行性脊柱病变中的应用效果尚未有明确的科学证据支持。本研究旨在针对椎间盘病变及退行性脊柱损伤患者开展肌内效贴治疗的已发表临床试验进行系统分析。为此,本研究依照PRISMA指南,在PubMed、Web of Science(WOS)、Scopus、Medline及Cinahl数据库中开展了文献检索。在偏倚风险与方法学质量评价环节,本研究采用了PEDro量表、Van Tulder标准及考克兰协作网(Cochrane Collaboration)的偏倚风险分析工具。最终共纳入5篇文献,其在PEDro量表上的平均得分为6.2分。现有中等质量证据表明,短期内肌内效贴可减少镇痛药物消耗量,并改善后侧肌群的活动度与肌肉力量。此外,现有有限证据显示肌内效贴可提升患者生活质量,但关于其对疼痛的改善效果,现有科学证据尚存矛盾。在获得更具确定性的研究结果并评估长期疗效之前,临床应用肌内效贴治疗椎间盘病变及脊柱退行性病变时应保持谨慎。本研究证据等级为I级,属于系统综述。
创建时间:
2023-06-01



